Table 2.
Predominant STs in persistent and intermittent carriers
| Sequence type (ST) of S. aureus strains# |
Number of donors carrying each ST (% of donors carrying each ST)a |
Totalb | |
|---|---|---|---|
| Persistent | Intermittent | ||
| ST5 |
5 (19.2) |
8 (22.8) |
13 (21.3) |
| ST30 |
5 (19.2) |
6 (17) |
11 (18) |
| ST8 |
4 (15.4) |
6 (17) |
10 (16.4) |
| ST45 |
1 (3.8) |
2 (5.7) |
3 (4.9) |
| ST15 |
4 (15.4) |
0 |
4 (6.5) |
| ST59 |
1 (3.8) |
2 (5.7) |
3 (4.9) |
| ST188 | 1 (3.8) | 3 (8.5) | 4 (6.5) |
#Only nasal swabs from carriers sampled 2 or more times were included and only the most prominent STs prevalent in North America are presented here.
aPercentage calculated using the total number of persistent and intermittent carriers in the cohort.
bTotal number persistent and intermittent carriers that carried one or more strains in their noses.